<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04586387</url>
  </required_header>
  <id_info>
    <org_study_id>HM20018505</org_study_id>
    <nct_id>NCT04586387</nct_id>
  </id_info>
  <brief_title>The Effect of Brain Anatomy on the Efficacy of Brain Stimulation Therapy</brief_title>
  <official_title>The Effect of Brain Anatomy on the Efficacy of Brain Stimulation Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Virginia Commonwealth University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to determine whether brain anatomy impacts the efficacy&#xD;
      of transcranial magnetic stimulation (TMS) which is a form of non-invasive brain stimulation.&#xD;
      TMS is used to stimulate different areas of the brain and it is well tolerated and generally&#xD;
      a safe procedure. It has been studied by researchers for 20 plus years. This brain&#xD;
      stimulation device and technique used in this study is an investigational device that has not&#xD;
      been approved by the U.S. FDA for treating any muscle or nerve problems. A copy of the device&#xD;
      brochure can be found at: https://www.magstim.com/product/rapid-family/&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 9, 2020</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in corticomotor excitability</measure>
    <time_frame>approximately 7 days</time_frame>
    <description>The amplitude the motor evoked potentials (MEPS) will be used to determine level of corticomotor excitability</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Active brain stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Inactive brain stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>inactive TMS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>intermittent theta burst stimulation (iTBS)</intervention_name>
    <description>repetitive non-invasive brain stimulation protocol which feels like many quick, light taps on your head</description>
    <arm_group_label>Active brain stimulation</arm_group_label>
    <arm_group_label>Inactive brain stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  nonimpaired individuals&#xD;
&#xD;
          -  free of contraindications for MRI and TMS&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  musculoskeletal injury of the arm&#xD;
&#xD;
          -  neurologic deficit affecting motor or sensory function&#xD;
&#xD;
          -  concurrent severe medical illness&#xD;
&#xD;
          -  diagnosis of SARS-CoV2, or symptoms consistent with COVID-19, or close contact with&#xD;
             someone with SARS-CoV2 in the past 3 weeks&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carrie Peterson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Commonwealth University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carrie Peterson, PhD</last_name>
    <phone>(804) 827-5270</phone>
    <email>clpeterson@vcu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ravi Hadimani</last_name>
    <phone>(804) 828-3679</phone>
    <email>rhadimani@vcu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>October 7, 2020</study_first_submitted>
  <study_first_submitted_qc>October 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 14, 2020</study_first_posted>
  <last_update_submitted>December 1, 2020</last_update_submitted>
  <last_update_submitted_qc>December 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>transcranial magnetic stimulation</keyword>
  <keyword>non-invasive brain stimulation</keyword>
  <keyword>magnetic resonance imaging</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

